Krystal Biotech Inc (KRYS)

Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	392.55% 42.14	8.556	-	-	-
Operating Expenses	12.90% 39.01	34.55	38.05	48.82	34.77
Benefits Costs and Expenses	37.80	-	-	-	-
Costs And Expenses	342.03% -83.62	34.55	-	-	-
Operating Income/Loss	112.07% 3.138	-25.99	-38.05	-48.82	-34.77
Income/Loss From Continuing Operations Before Tax	49.26% 4.341	8.556	-33.21	-45.30	-32.05
Income/Loss From Continuing Operations After Tax	89.24% 8.692	80.75	-33.21	-45.30	-32.05
Net Income/Loss	89.24% 8.692	80.75	-33.21	-45.30	-32.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.78% 0.3419	28.04	26.66	25.71	0.0636
Diluted Average Shares	98.73% 0.3673	28.89	26.66	25.71	0.0636
Basic Earnings Per Share	88.89% 0.32	2.88	-1.25	-1.76	-1.25
Diluted Earnings Per Share	88.89% 0.31	2.79	-1.25	-1.76	-1.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-